Spevigo 450 mg/7.5 mL (60 mg/mL) single-dose vial Images
Generic Name: spesolimab
This medication has been identified as Spevigo 450 mg/7.5 mL (60 mg/mL) single-dose vial and is used for Generalized Pustular Psoriasis. It belongs to the drug class interleukin inhibitors and is not a controlled substance.
Images of medication
Spevigo
- Generic Name
- spesolimab
- Strength
- 450 mg/7.5 mL (60 mg/mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00597-0035
See also:
More about Spevigo (spesolimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.